Excelya operates a 900+ person clinical research organization across 28 countries, serving biotech and pharma clients through full-service trial operations and regulatory consulting. The tech stack reveals active migration toward cloud analytics: dbt, GCP, and Streamlit adoption alongside legacy SAP and Oracle, paired with hiring acceleration in data and research roles. Pain-point data shows classical CRO scaling challenges—multi-site compliance, hard-to-fill clinical roles, and reporting delays—that the company is addressing via e2b data standardization and quality management system rollout.
Excelya is a full-service contract research organization (CRO) founded in 2014, headquartered in Paris, and operating across Europe, North America, and India. The company serves biotech, pharma, and medical device organizations across oncology, rare disease, infectious disease, immunotherapy, and CNS therapeutics. Core service lines span clinical operations, regulatory affairs, biometrics, medical writing, pharmacovigilance, and late-phase studies. With 900+ employees split across healthcare, research, data, operations, and legal functions, Excelya combines hands-on trial execution with emerging data infrastructure capabilities—dbt pipelines, cloud analytics on GCP, and regulatory data interchange (e2b) systems. Current hiring shows sustained momentum in clinical research, data engineering, and operations roles, indicating growth in both trial volume and internal analytics maturity.
Core stack: SAP, Excel, Power BI, dbt, Python, SAS, SQL, and Veeva Vault for regulatory data. Analytics layer includes Streamlit, GraphPad Prism, and GCP. Clinical data standards: CDISC, e2b, Oracle SQL Developer.
Headquartered in Boulogne-Billancourt, Paris. Active in 28 countries across Europe, USA, and India. Current hiring spans France, India, Greece, Belgium, Bulgaria, United Kingdom, Poland, Hungary, and United States.
Other companies in the same industry, closest in size